Novel glycosyl donor with triisopropylsilyl non-participating group in benzylfree stereoselective 1,2-cis-galactosylation (PhCO)), 129.42 (C-1 (PhCO)), 129.45 (C-1 (PhCO)), 129.46 (C-2(6) (PhCO)), 129.6 (C-2(6) (PhCO)), 129.70 (C-2(6) (PhCO)), 129.74 (C-2(6) (PhCO)), 129.87 (C-2(6) (PhCO)), 129.94 (C-1 (PhCO)), 132.7 (C-4 (PhCO)), 132.9 (C-4 (PhCO)), 133. 
Methyl 3,4,6-tri-O-benzoyl-2-O-[3,4,6-tri-O-benzoyl-2-O-(triisopropylsilyl)-α-Dgalactopyranosyl]-β-D-galactopyranoside (14)
R
4-(3-Chloropropoxy)phenyl 4-O-(β-D-galactopyranosyl)-β-D-glucopyranoside (20)
CPP lactoside (19) (1.596 g, 1.98 mmol) was dissolved in MeOH (32 mL) and 1 M MeONa (0.12 mL) was added to the reaction mixture, which then was stirred at ~20 °C for 20 h. When the reaction was complete, H 2 O (7 mL) was added to the suspension formed, which led to immediate dissolution of the solids. The reaction mixture was neutralized with ion-exchange 
4-(3-Chloropropoxy)phenyl 4-O-(4,6-O-benzylidene-β-D-galactopyranosyl)-β-Dglucopyranoside (21)
Heptaol 20 (0.899 g, 1.76 mmol) was suspended in anhydrous acetonitrile (25 mL).
Benzaldehyde dimethyl acetal (0.4 ml, 2.6 mmol) was added followed by p-TsOH·H (PhCO)), 129.62 (C-2(6) (PhCO)), 129.66 (C-2(6) (PhCO)), 129.68 (C-1 (PhCO)), 129.72 (C-2(6) (PhCO)), 129.8 (C-2(6) (PhCO)), 129.9 (C-2(6) (PhCO)), 133.0 (C-4 (PhCO)), 133. 
4-(3-Chloropropoxy)phenyl 2,3,6-tri-O-benzoyl-4-O-(2,3-di-O-benzoyl-β-Dgalactopyranosyl)-β-D-glucopyranoside (23)
Benzylidene derivative 22 (1g, 0.89 mmol) was dissolved in DCM (30 mL) and cooled to °C.
Trifluoroacetic acid (6 mL) was added, followed by water (1 mL). The reaction mixture was stirred for 4 h at 0 °C and concentrated under reduced pressure. The residue was dissolved in CHCl 3 (40 mL), washed with satd aq NaHCO 3 (3 × 40 mL), and with satd aq NaCl (2 × 40 mL).
The reaction mixture was transferred to an extraction funnel, washed with satd aq NaHCO 3 and concentrated under reduced pressure. 
4-(3-Chloropropoxy)phenyl 2,3,6-tri-O-benzoyl-4-O-(2,3,6-tri-O-benzoyl-β-Dgalactopyranosyl)-β-D-glucopyranoside (24)
To a solution of diol 23 (300 mg, 0.29 mmol) in anhydrous CH 2 Cl 2 (6 mL), Py (3 mL) and BzCl 73 mg, 0.72 mmol) was then added, the volatiles were distilled off on a rotary evaporator, the residue (white foam) was dissolved in MeOH (2 mL), diluted with toluene (20 mL), and the volatiles were again distilled off on a rotary evaporator.
The residue was dissolved in MeOH (9 mL), water (1 mL) was added, followed by AcOH (0.05 mL), and the solution was stirred under reflux (bath temperature 80 °C) for 2 h. After cooling to ~23 °C, the solution was concentrated under reduced pressure to a semisolid. To remove the traces of the protic solvents, the residue was first dissolved in MeOH (3 mL), diluted with toluene (20 mL) and concentrated under reduced pressure. The crystals formed were coevaporated with toluene two times by suspending them in toluene (20 mL), and distilling off the volatiles on a rotary evaporator at 50-55 °C (bath temperature). The solid residue of 4-(3-
was dried to a constant mass in a vacuum of an oil pump (0.2 mbar) and used in the next step without purification.
The crude isopropylidene derivative obtained at the previous step was dissolved in anhydrous Py (10 mL) under argon atmosphere, the solution was cooled in an ice-water bath, and benzoyl chloride (1.32 mL, 1.60 g, 11.4 mmol) was added dropwise with stirring. After 15 min the cooling bath was removed, and the suspension formed was stirred at 20-23 °C for 20 h. Then the S15 reaction mixture was cooled in an ice-water bath, water (1.0 mL) was added dropwise with stirring, and, after 20 min stirring, the resulting slurry was distributed between water (40 mL) and 1 : 1 (v/v) t-BuOMe-EtOAc mixture (40 mL). The organic layer was separated, the aqueous layer was extracted with EtOAc (3 × 15 mL), the combined organic extracts were filtered through a cotton wool plug, concentrated under reduced pressure (bath temperature 45 °C), and dried in a vacuum of an oil pump (0.2 mbar). The residue was dissolved in CHCl 3 (40 mL), washed with 1 M aq NaHSO 4 (20 ml), then with water (20 mL). The combined aqueous washings were back-extracted with CHCl 3 (10 mL). The organic extracts were washed with 1 M aq Na 2 CO 3 (2 × 40 mL), and the washings were back-extracted with CHCl 3 (10 mL). The combined extracts were filtered through a cotton wool plug, concentrated under reduced pressure (bath temperature 45 °C), and dried in a vacuum of an oil pump (0.2 mbar) to give crude 4-(3-
) as a solid.
The crude pentabenzoate obtained at the previous step was dissolved in CH 2 Cl 2 (30 mL), cooled in an ice-water bath, water (0.5 mL) was added with stirring, followed by trifluoroacetic acid were added with stirring, and the solution was stirred at 23 °C for 1 h (the reaction is complete according to TLC). Then Py (0.050 mL, 49 mg, 0.62 mmol) was added, and the volatiles were distilled off on a rotary evaporator (bath temperature 50 °C). The residue was suspended in a mixture of AcOH (12 mL) and water (3 ml), heated until all the solids dissolved (~60 °C) and the mixture was stirred at 20-23 °C for 20 h. Then the solution (containing a small amount of an amorphous precipitate) was concentrated under reduced pressure, the residue was co-evaporated S17 with water (15 mL), then with toluene (15 mL), the resulting yellowish syrup was dissolved in toluene (20 mL) and washed with 1 M aq Na 2 CO 3 (10 mL). The aqueous layer was backextracted with toluene (3 × 5 mL). The combined organic phases were dried (Na 2 SO 4 ) and concentrated under reduced pressure. The resulting syrup was purified by column chromatography on silica gel (gradient 5→33% EtOAc in toluene). The fractions containg the main product were pooled, concentrated under reduced pressure, and the residue (white foam, 610 mg) was lyophilized from benzene (10 mL) (Caution! Benzene is a proven carcinogen!) to
give the 3-hydroxy derivative (590 mg, 87%) as a light, very brittle white amorphous solid. Chloropropoxy)phenyl 2,3,6-tri-O-benzoyl-4-O-[2,4,6-tri-O-benzoyl-3-O-(3,4,6- 
4-(3-

